Compare KNDI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNDI | PAVM |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | China | United States |
| Employees | N/A | 41 |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.8M | 57.8M |
| IPO Year | 2021 | N/A |
| Metric | KNDI | PAVM |
|---|---|---|
| Price | $0.73 | $9.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 87.3K | 9.3K |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $0.21 |
| 52 Week High | $1.77 | $28.44 |
| Indicator | KNDI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 44.98 |
| Support Level | N/A | $9.05 |
| Resistance Level | $0.87 | $9.26 |
| Average True Range (ATR) | 0.04 | 0.35 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 12.90 | 8.18 |
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.